Fundraising FoxBroadOak Capital Partners — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Pluristyx develops induced pluripotent stem cell (iPSC) technologies, including non-modified and genetically engineered cell lines, proprietary gene edits, and reprogramming platforms, along with related services.
BiotechDeep TechMedical DevicesSeattle, US
Benjamin Fryer(Co-Founder and Chief Executive Officer)inJason Carstens(Executive Officer, Director)Trent Carrier(Director)
Quartzy provides a platform for lab management and research resource optimization, serving life scientists, lab managers, and academic institutions.
BiotechDeep TechE-commerceEnterprise SoftwareHealthtechSaaSSan Francisco, US
Jayant Kulkarni(CEO)inAdam Regelmann(CPO)inAjoy Sojan(CTO)sylvie.dao@quartzy.comTristan Pemble(Director of Engineering)Courtney Bogaard(Director of HR)
Co-investorsA.Capital VenturesBling CapitalLerer HippeauMultiplier CapitalSilicon BadiaTeamworthy Ventures+10 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.